Rate, Time Course, and Predictors of Implantable Cardioverter Defibrillator Infections: An Analysis From the SIMPLE Trial by François Philippon, MD, FRCPC, FHRS, FCCS, Gilles E. O’Hara, MD, Jean Champagne, MD, Stefan H. Hohnloser, MD, Michael Glikson, MD, Jörg Neuzner, MD, Philippe Mabo, MD, Xavier Vinolas, MD, Josef Kautzner, MD, Fredrik Gadler, MD, Noa Lashevsky, Stuart J. Connolly, MD, Yan Y. Liu, MSc, Jeff S. Healey, MD

“…Over an average of 3.1 years, patients were seen every 6 months and examined for evidence of ICD infection, which was defined as requiring device removal and/or intravenous antibiotics. Results: Within 24 months, 21 patients (0.8%) developed infection. …”
Get full text

Diagnosis of Helicobacter pylori infection in patients with bleeding ulcer disease: rapid urease test and histology Diagnóstico mediante endoscopia de la infección por Helicobacter... by M. Castro-Fernández, D. Sánchez-Muñoz, E. García-Díaz, J. Miralles-Sanchiz, J. Vargas-Romero

“…None of the patients had received treatment for H. pylori, proton pump inhibitors or antibiotics in the two weeks prior to the upper gastrointestinal bleeding episode. …”
Get full text

Selected Abstracts of the 12th International Congress of UENPS; Krakow (Poland); September 2nd-4th, 2022 by --- Various Authors

“…LIMOSILACTOBACILLUS REUTERI DSM 17938 IN THE PREVENTION OF FUNCTIONAL GASTROINTESTINAL DISORDERS IN NEO­NATES TREATED WITH ANTIBIOTICS: A RANDOMIZED CONTROLLED TRIAL • J. Lozar Krivec, G. …”
Get full text

Identification of a Family of Glycoside Derivatives Biologically Active against <i>Acinetobacter baumannii</i> and Other MDR Bacteria Using a QSPR Model by Francisco José Palacios-Can, Jesús Silva-Sánchez, Ismael León-Rivera, Hugo Tlahuext, Nina Pastor, Rodrigo Said Razo-Hernández

“…<i>Acinetobacter baumannii</i> has emerged as a highly virulent Gram-negative bacterium that has acquired multiple resistance mechanisms against antibiotics and is considered of critical priority. …”
Get full text

A randomized, double-blind, positive-controlled, Phase-II clinical trial to evaluate efficacy and safety of Fuke Qianjin capsule in Pakistani patients with pelvic inflammatory dise... by Muhammad Raza Shah, Sehrosh Naz Khan, Samreen Fatima, Liangyuan Yao, Hongbo Yuan, Shafi Ullah, Jahanara Ainuddin, Changqing Zeng, Yiyang Zheng, Najmus Sahar, Shaista Anwar, Meijun Zhu, Cun Ma, Kaweeta Kumari, Wei Wang, Wei Wang, Ruihuan Liu

“…Ethnopharmacological relevance: Pelvic inflammatory disease (PID) is a frequently occurring gynecological disorder mainly caused by the inflammation of a woman’s upper genital tract. Generally, antibiotics are used for treating PID, but prolonged use poses potential risks of gut bacterial imbalance, bacterial resistance, super bacteria production, and associated adverse reactions. …”
Get full text

Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study pro... by Pascal Urwyler, Panteleimon Charitos, Stephan Moser, Ingmar A. F. M. Heijnen, Marten Trendelenburg, Reto Thoma, Johannes Sumer, Adrián Camacho-Ortiz, Marcelo R. Bacci, Lars C. Huber, Melina Stüssi-Helbling, Werner C. Albrich, Parham Sendi, Michael Osthoff

“…SOC treatment will be administered according to local institutional guidelines, including supplemental oxygen, antibiotics, corticosteroids, remdesivir, and anticoagulation. …”
Get full text

Detection of genetic mutations in inh A and kat G for isoniazid and its association with rifampicin resistance in tuberculosis confirmed by line probe assay: Its rationality for is... by Prasanta Kumar Das, Somtirtha B Ganguly, Bodhisatya Mandal

“…Although there are several guidelines, proper rationale to the use of antibiotics as an effective prophylaxis is yet an area to be discussed. …”
Get full text

Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial an... by R Pickard, T Lam, G MacLennan, K Starr, M Kilonzo, G McPherson, K Gillies, A McDonald, K Walton, B Buckley, C Glazener, C Boachie, J Burr, J Norrie, L Vale, A Grant, J N’Dow

“…This was defined as any symptom reported during catheterisation, up to 3 days or 1 or 2 weeks post catheter removal or 6 weeks post randomisation combined with a prescription of antibiotics, at any of these times, for presumed symptomatic UTI. …”
Get full text

Inflammatory Pseudotumor of the Maxillary Sinus by Johann F. Castañeda, Jeffrey S. Concepcion, Ricardo L. Ramirez, Kirt Areis Delovino

“…Contrast-enhanced MRI of the nasopharynx showed a large expansile left maxillary sinus lesion bulging into the nasal cavity, extending into adjacent lateral orbital soft tissue and extending into the buccal space through an apparently disrupted left inferolateral maxillary wall. Intravenous antibiotics and a high-dose steroid trial resulted in complete disappearance of the left infraorbital mass and discharge within a week, and the patient was discharged on a tapering steroid dose.     …”
Get full text

Cobertura y barreras de la vacunación contra la varicela en niños que consultaron a la Fundación Salud Bosque by Gustavo Adolfo Carvajal-Barrios, Nicolás Ignacio Ramos-Rodríguez

“…Only 9 patients (33%) had received the first dose of the vaccine, and none had received the second dose. 92.5% required sick leave, 89% required painkillers, 63% required antihistamines, and 26% required antibiotics. Discussion. The conducted study shows a significantly lower incidence compared to other international cohorts. …”
Get full text

Photooxidation of pinonaldehyde at ambient conditions investigated in the atmospheric simulation chamber SAPHIR by M. Rolletter, M. Blocquet, M. Blocquet, M. Kaminski, M. Kaminski, B. Bohn, H.-P. Dorn, A. Hofzumahaus, F. Holland, X. Li, X. Li, F. Rohrer, R. Tillmann, R. Wegener, A. Kiendler-Scharr, A. Wahner, H. Fuchs

Get full text

MicroRNA-30a inhibits cell proliferation in a sepsis-induced acute kidney injury model by targeting the YAP-TEAD complex by Junfeng Su, Ying Wang, Jing Xie, Long Chen, Xinxin Lin, Jiandong Lin, Xiongjian Xiao

“…Fluid resuscitation with 30 mL/kg 37 °C saline was administered after the operation, without antibiotics. Formalin-fixed, paraffin-embedded kidney sections were stained with hematoxylin and eosin. …”
Get full text

Micropollutant removal and nutrient recovery for sustainable management of urban wastewater by Zhang, Jiefeng

“…In Chapter 6, the study further investigated the removal of a selected group of 13 cytostatic drugs (including 3 alkylating agents, 2 antimetabolites, 1 plant alkaloid, 3 cytotoxic antibiotics, and 4 hormone antagonists) using FO membrane process. …”
Get full text

Development of ginger essential oils-nanobactericides for controlling bacterial leaf blight disease of rice caused by Xanthomonas oryzae pv. oryzae by Abdullahi, Adamu

“…The Dimethyl sulfoxide (DMSO) treatment (control) showed a normal rod shape cell, while treatment with the ginger EOs showed irregular shape with sunken surfaces, and treatment with antibiotics display abnormal growth of the cells. The ginger EOs display a wide range of activity against the pathogen. …”
Get full text

Assessment of shallow groundwater pollution by poultry waste in Minna, Nigeria by Aderemi, Adeoye Peter

“…The high heavy metals concentration was suspected to have originated from the addition of some antibiotics to poultry feeds for improved performance as shown in the feed composition. …”
Get full text

Genome-Wide Identification and Expression Pattern of ABC Transporters in Razor Clam (Sinonovacula constricta) by Fan YANG, Zhiping LI, Yinghui DONG, Jianfeng REN

“…By utilizing the energy released by ATP hydrolysis, ABC transporters function to transfer amino acids, lipids, antibiotics, and many other substances across membranes, thereby participating in various physiological processes such as nutrition uptake, antigen presentation, drug excretion, and lipid homeostasis in living organisms. …”
Get full text

Current research in biotechnology: Exploring the biotech forefront by Andy Wai Kan Yeung, Nikolay T. Tzvetkov, Vijai K. Gupta, Subash C. Gupta, Gorka Orive, Günther K. Bonn, Bernd Fiebich, Anupam Bishayee, Thomas Efferth, Jianbo Xiao, Ana Sanches Silva, Gian Luigi Russo, Maria Daglia, Maurizio Battino, Ilkay Erdogan Orhan, Ferdinando Nicoletti, Michael Heinrich, Bharat Bhushan Aggarwal, Marc Diederich, Maciej Banach, Wolfram Weckwerth, Rudolf Bauer, George Perry, Edward A. Bayer, Lukas A. Huber, Jean-Luc Wolfender, Robert Verpoorte, Francisco A. Macias, Michael Wink, Marc Stadler, Simon Gibbons, Alejandro Cifuentes, Elena Ibanez, Gérard Lizard, Rolf Müller, Michael Ristow, Atanas G. Atanasov

Get full text

Emergence of a Plasmid-Encoded Resistance-Nodulation-Division Efflux Pump Conferring Resistance to Multiple Drugs, Including Tigecycline, in <named-content content-type="genus-spec... by Luchao Lv, Miao Wan, Chengzhen Wang, Xun Gao, Qiwen Yang, Sally R. Partridge, Yang Wang, Zhiyong Zong, Yohei Doi, Jianzhong Shen, Peiyao Jia, Qianhua Song, Qianhui Zhang, Jun Yang, Xianhui Huang, Minggui Wang, Jian-Hua Liu

Get full text

Re:GEN Open: The Impact of Genomics and Biotechnology on the Future of Medicine by Vasu Punj

“…Biotechnology companies use microbes to create new therapeutic agents, such as monoclonal antibodies, antibiotics, vaccines, and hormones. Five years ago, scientists at J. …”
Get full text

BCG revaccination of health workers in Brazil to improve innate immune responses against COVID-19: A structured summary of a study protocol for a randomised controlled trial by Ana Paula Junqueira-Kipnis, Laura Raniere Borges dos Anjos, Lília Cristina de Souza Barbosa, Adeliane Castro da Costa, Kellen Christina Malheiros Borges, Amanda da Rocha Oliveira Cardoso, Kaio Mota Ribeiro, Sarah Brena Aparecida Rosa, Carine de Castro Souza, Rogério Coutinho das Neves, Guylherme Saraiva, Sueli Meira da Silva, Erika Aparecida da Silveira, Marcelo Fouad Rabahi, Marcus Barreto Conte, André Kipnis

“…Participants with any of the following characteristics will be excluded: - Have had in the last fifteen days any signs or symptoms of virus infection, including COVID-19; - Have had fever in the last fifteen days; - Have been vaccinated fifteen days before the inclusion; - Have a history or confirmation of any immunosuppressive disease such as HIV, presented solid tumour in the last two years or autoimmune diseases; - Are under preventive medication with antibiotics, steroid anti-inflammatories, or chemotherapy; - Have less than 500 neutrophils per mL of blood; - Have previously been diagnosed with tuberculosis; - Are breastfeeding or pregnant; - Are younger than 18 years old; - Are participating as an investigator in this clinical trial. …”
Get full text